154 related articles for article (PubMed ID: 2449824)
1. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma.
Johnson DE; Herndier BG; Medeiros LJ; Warnke RA; Rouse RV
Am J Surg Pathol; 1988 Mar; 12(3):187-97. PubMed ID: 2449824
[TBL] [Abstract][Full Text] [Related]
2. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
[TBL] [Abstract][Full Text] [Related]
3. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects.
Fischer HP; Altmannsberger M; Weber K; Osborn M
Am J Pathol; 1987 Jun; 127(3):530-7. PubMed ID: 2438941
[TBL] [Abstract][Full Text] [Related]
4. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Ma CK; Zarbo RJ; Frierson HF; Lee MW
Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry in the differential diagnosis of liver carcinomas.
Hurlimann J; Gardiol D
Am J Surg Pathol; 1991 Mar; 15(3):280-8. PubMed ID: 1847609
[TBL] [Abstract][Full Text] [Related]
7. The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type.
Akiba J; Nakashima O; Hattori S; Naito Y; Kusano H; Kondo R; Nakayama M; Tanikawa K; Todoroki K; Umeno Y; Nakamura K; Sanada S; Yamaguchi R; Ogasawara S; Yano H
J Clin Pathol; 2016 Oct; 69(10):846-51. PubMed ID: 26969740
[TBL] [Abstract][Full Text] [Related]
8. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
9. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
Maeda T; Adachi E; Kajiyama K; Sugimachi K; Tsuneyoshi M
Hum Pathol; 1995 Sep; 26(9):956-64. PubMed ID: 7545644
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type.
Fisher HP; Doppl W; Osborn M; Altmannsberger M
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(2):71-6. PubMed ID: 2467436
[TBL] [Abstract][Full Text] [Related]
11. [Primary malignant neoplasms of the liver. Contribution of echography to the preoperative diagnosis].
Lovotti D; De Angelis G; Buonocore M; Belisomo M; Tinozzi S; Maucci A
Minerva Chir; 1989 Oct; 44(19):2059-64. PubMed ID: 2559363
[TBL] [Abstract][Full Text] [Related]
12. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
[TBL] [Abstract][Full Text] [Related]
13. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
Stroescu C; Herlea V; Dragnea A; Popescu I
J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7.
Ramos-Vara JA; Miller MA; Johnson GC
Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796
[TBL] [Abstract][Full Text] [Related]
16. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma.
Leong AS; Sormunen RT; Tsui WM; Liew CT
Histopathology; 1998 Oct; 33(4):318-24. PubMed ID: 9822920
[TBL] [Abstract][Full Text] [Related]
17. [An immunohistochemical study on primary carcinoma of the liver].
Seo JK
J UOEH; 1989 Dec; 11(4):429-39. PubMed ID: 2481871
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas.
Lai YS; Thung SN; Gerber MA; Chen ML; Schaffner F
Arch Pathol Lab Med; 1989 Feb; 113(2):134-8. PubMed ID: 2464975
[TBL] [Abstract][Full Text] [Related]
19. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
20. Blood-group-related antigen Lewis(x) and Lewis(y) in the differential diagnosis of cholangiocarcinoma and hepatocellular carcinoma.
Jovanovic R; Jagirdar J; Thung SN; Paronetto F
Arch Pathol Lab Med; 1989 Feb; 113(2):139-42. PubMed ID: 2537068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]